PIN15 COST-EFFECTIVENESS ANALYSIS OF 1-YEAR PEGINTERFERON ALFA-2A VERSUS 3 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA

Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)73295-8
https://www.valueinhealthjournal.com/article/S1098-3015(11)73295-8/fulltext
Section Title : RESEARCH POSTER ABSTRACTS
Section Order : 1453
First Page : A549
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73295-8&doi=10.1016/S1098-3015(11)73295-8
HEOR Topics :
Tags :
Regions :